Effects of N-linked glycosylation of the fusion protein on replication of human metapneumovirus in vitro and in mouse lungs

Journal of General Virology

Volumn 92, Issue 7, 2011, Pages 1666-1675

  Zhang, Jinhui ^a   Dou, Ying ^a   Wu, Junfeng ^a   She, Weiwei ^a   Luo, Lizhong ^b   Zhao, Yao ^a   Liu, Ping ^a   Zhao, Xiaodong ^a  

^a CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b Canadian Science Centre for Human and Animal Health   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS FUSION PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; HUMAN METAPNEUMOVIRUS; IN VITRO STUDY; LUNG INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; SITE DIRECTED MUTAGENESIS; VIRUS REPLICATION;

AMINO ACID MOTIFS; ANIMALS; CELL LINE; FEMALE; GLYCOSYLATION; HUMANS; LUNG; MALE; METAPNEUMOVIRUS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PARAMYXOVIRIDAE INFECTIONS; VIRAL FUSION PROTEINS; VIRUS REPLICATION;

HUMAN METAPNEUMOVIRUS;

EID: 79959308468     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.030049-0     Document Type: Article

References (25)

1. Biacchesi, S., Skiadopoulos, M. H., Yang, L., Lamirande, E. W., Tran, K. C., Murphy, B. R., Collins, P. L. & Buchholz, U. J. (2004). Recombinant human metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J Virol 78, 12877-12887.
2. Biacchesi, S., Pham, Q. N., Skiadopoulos, M. H., Murphy, B. R., Collins, P. L. & Buchholz, U. J. (2005). Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J Virol 79, 12608-12613.
3. Boivin, G., Abed, Y., Pelletier, G., Ruel, L., Moisan, D., Coôté, S., Peret, T. C., Erdman, D. D. & Anderson, L. J. (2002). Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis 186, 1330-1334.
4. Buchholz, U. J., Finke, S. & Conzelmann, K. K. (1999). Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is notessential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73, 251-259.
5. Cattaneo, R. & Rose, J. K. (1993). Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J Virol 67, 1493-1502.
6. Chen, X., Zhang, Z. Y., Zhao, Y., Liu, E. M. & Zhao, X. D. (2010). Acute lower respiratory tract infections by humanmetapneumovirus in children in Southwest China: a 2-year study. Pediatr Pulmonol 45, 824-831.
7. Cimolai, N., Taylor, G. P., Mah, D. & Morrison, B. J. (1992). Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol Immunol 36, 465-478.
8. de Graaf, M., Herfst, S., Schrauwen, E. J., van den Hoogen, B. G., Osterhaus, A. D. & Fouchier, R. A. (2007). An improved plaque reduction virus neutralization assay for human metapneumovirus. J Virol Methods 143, 169-174.
9. Deffrasnes, C., Hamelin, M. E., Prince, G. A. & Boivin, G. (2008). Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus. Antimicrob Agents Chemother 52, 279-287.
10. Deng, R., Wang, Z., Mirza, A. M. & Iorio, R. M. (1995). Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology 209, 457-469.
11. Ebata, S. N., Coôté, M. J., Kang, C. Y. & Dimock, K. (1991). The fusion and hemagglutinin-neuraminidase glycoproteins of human parainfluenza virus 3 are both required for fusion. Virology 183, 437-441.
12. Herfst, S., de Graaf, M., Schickli, J. H., Tang, R. S., Kaur, J., Yang, C. F., Spaete, R. R., Haller, A. A., van den Hoogen, B. G. & other authors (2004). Recovery of human metapneumovirus genetic lineages A and B from cloned cDNA. J Virol 78, 8264-8270.
13. Horvath, C. M. & Lamb, R. A. (1992). Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: roles of conserved residues in cell fusion. J Virol 66, 2443-2455.
14. Jeffrey, S. K. (2006). Epidemiology of human metapneumovirus. Clin Microbiol Rev 19, 546-557.
15. Johnson, R. A., Prince, G. A., Suffin, S. C., Horswood, R. L. & Chanock, R. M. (1982). Respiratory syncytial virus infection in cyclophosphamide-treated cotton rats. Infect Immun 37, 369-373.
16. Miller, S. A., Tollefson, S., Crowe, J. E., Jr, Williams, J. V. & Wright, D. W. (2007). Examination of a fusogenic hexameric core from human metapneumovirus and identification of a potent synthetic peptide inhibitor from the heptad repeat 1 region. J Virol 81, 141-149.
17. Olszewska-Pazdrak, B., Casola, A., Saito, T., Alam, R., Crowe, S. E., Mei, F., Ogra, P. L. & Garofalo, R. P. (1998). Cell-specific expression of RANTES, MCP-1, and MIP-1a by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol 72, 4756-4764.
18. Ottolini, M. G., Curtis, S. R., Mathews, A., Ottolini, S. R. & Prince, G. A. (2002). Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model. Bone Marrow Transplant 29, 117-120.
19. Schowalter, R. M., Smith, S. E. & Dutch, R. E. (2006). Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J Virol 80, 10931-10941.
20. Skiadopoulos, M. H., Biacchesi, S., Buchholz, U. J., Amaro-Carambot, E., Surman, S. R., Collins, P. L. & Murphy, B. R. (2006). Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity. Virology 345, 492-501.
21. Smith, E. C., Popa, A., Chang, A., Masante, C. & Dutch, R. E. (2009). Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS J 276, 7217-7227.
22. Tanabayashi, K. & Compans, R. W. (1996). Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. J Virol 70, 6112-6118.
23. Tong, S. & Compans, R. W. (1999). Alternative mechanisms of interaction between homotypic and heterotypic parainfluenza virus HN and F proteins. J Gen Virol 80, 107-115.
24. van den Hoogen, B.G., de Jong, J. C., Groen, J., Kuiken, T., de Groot, R., Fouchier, R. A. & Osterhaus, A. D. (2001). A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 7, 719-724.
25. Zhao, X., Chen, F. P., Megaw, A. G. & Sullender, W. M. (2004). Variable resistance to palivizumab in cotton rats by respiratory syncytial virus mutants. J Infect Dis 190, 1941-1946.